IQVIA™ Real-World Insights Bibliography

Changes in HbA1c, Body Weight, and Systolic Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Therapy: A Primary Care Database Study
Author(s): Scheerer M, Rist R, Proske O, Meng A, Kostev K
Affiliations(s): 
Publication(s):  Diabetes Metab Syndr Obes. 2016 Oct 31;9:337-345.
Document Type(s): Article,
Countries: 
C:
Y:
Cardiovascular disease, Diabetes, Metabolic Disorders ,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
Author(s): Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F.
Affiliations(s): 
Publication(s):  Rheumatol Ther. 2016 Jun;3(1):53-75.
Document Type(s): Article,
Countries: France, Germany, UK, USA,
C:
Y:
Health economics, Health policy, Metabolic Disorders , Public Health,
2016
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Type 2 Diabetes Patients in Germany
Author(s): Qiao Q, Grandy S, Ouwens M, Kostev K
Affiliations(s): 
Publication(s):  Diabetes Metab Syndr Obes. 2016 Jun 28;9:201-5
Document Type(s): Article,
Countries: Germany,
C:
Y:
Diabetes, Metabolic Disorders ,
2016
  L:
A:
English
  Add to report
 
 
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records.
Author(s): Kolaczynski WM, Hankins M, Ong SH, Richter H, Clemens A, Toussi M.
Affiliations(s): 
Publication(s):  Diabetes Ther. 2016 Sep;7(3):483-96. doi: 10.1007/s13300-016-0177-8.
Document Type(s): Article,
Countries: Germany,
C:
Y:
Cardiovascular disease, Diabetes, Metabolic Disorders ,
2016
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.
Author(s): Maina G1, Ripellino C2
Affiliations(s): 1 Department of Neurosciences, University of Torino, Torino, 2 CSD Medical Research S.R.L, Milan, Italy
Publication(s):  Expert Opin Drug Saf. 2014 Sep;13(9):1149-54. doi: 10.1517/14740338.2014.943732. Epub 2014 Jul 18.
Document Type(s): Article,
Countries: Italy, Spain,
Click here for the abstract
C:
Y:
Mental health, Metabolic Disorders ,
2014
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors].
Author(s): Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2
Affiliations(s): 1 GH Cochin Hôtel-Dieu, Paris 2 IMS Health HEOR, La Défense
Publication(s):  Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris
Document Type(s): Poster,
Countries: France,
C:
Y:
Diabetes, Endocrinology, Metabolic Disorders ,
2014
  L:
A:
French
Retrospective database analysis,
  Add to report
 
 
Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study.
Author(s): Banegas JR1, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Sazova O, Perk J, Steg PG, De Backer G, Rodríguez-Artalejo F.
Affiliations(s): 1Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid/IdiPAZ, CIBER of Epidemiology and Public Health, Madrid, Spain
Publication(s):  Int J Cardiol. 2013 Jun 5;166(1):210-4. doi: 10.1016/j.ijcard.2011.10.094. Epub 2011 Nov 5
Document Type(s): Article,
Countries: Europe,
Click here for the abstract
C:
Y:
Metabolic Disorders ,
2013
  L:
A:
English
Prospective study,
  Add to report
 
 
Gilbert's syndrome and the risk of death: a population-based cohort study.
Author(s): Horsfall LJ, Nazareth I, Pereira SP & Petersen I
Affiliations(s): UCL Research Department of Primary Care and Population Health
Publication(s):  J Gastroenterol Hepatol. 2013 Oct;28(10):1643-7. doi: 10.1111/jgh.12279.
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Hematology, Metabolic Disorders ,
2013
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Multilevel Analysis of the Influence of Patients? and General Practitioners? Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France
Author(s): Pichetti S(1), Sermet C(1), Godman B(2,3,4), Campbell SM(5), Gustafsson LL(2).
Affiliations(s): IRDES(1),universités Glasgow(3), Liverpool(4), Manchester(5), Stockholm(2)
Publication(s):  Appl Health Econ Health Policy. 2013 Jun;11(3):205-18.
Document Type(s): Article,
Countries: 
C:
Y:
Metabolic Disorders ,
2013
  L:
A:
English
  Add to report
 
 
An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study.
Author(s): Delemer B, Aubert JP, Nys P, Landron F, Bouée S.
Affiliations(s): 
Publication(s):  Eur J Endocrinol. 2012 Dec;167(6):817-23. doi: 10.1530/EJE-11-1041. Epub 2012 Oct 3.
Document Type(s): Article,
Countries: France,
Click here for the abstract
C:
Y:
Metabolic Disorders ,
2012
  L:
A:
English
  Add to report
 
 
First Page Previous Page  2 of 3 Next Page Last Page